Suppr超能文献

结构化专家咨询法为晚期肾细胞癌长期生存推断提供信息

Structured Expert Elicitation to Inform Long-Term Survival Extrapolations in Advanced Renal Cell Carcinoma.

作者信息

Lee Dawn, Ahmad Zain, Larkin James M G, Bahl Amit, Melendez-Torres G J

机构信息

PenTAG, University of Exeter, University of Exeter Medical School, South Cloisters, St Luke's Campus, Exeter, EX1 2LU, UK.

Royal Marsden NHS Foundation Trust, London, UK.

出版信息

Appl Health Econ Health Policy. 2025 Aug 27. doi: 10.1007/s40258-025-01000-8.

Abstract

BACKGROUND

In the absence of long-term data, structured expert elicitation gathers expert judgments and associated uncertainties to assess the clinical plausibility of long-term extrapolations.

OBJECTIVE

The objective of this study was to obtain expert estimates of expected long-term outcomes for advanced renal cell carcinoma treatments to inform cost-effectiveness analysis for National Institute for Health and Care Excellence (NICE)'s pathways pilot.

METHODS

Using materials from the structured expert elicitation resources (STEER) repository, aligned with the Medical Research Council (MRC) protocol, the exercise was planned and conducted. Aiming for 5-10 oncologists from diverse UK geographies and settings, experts estimated progression-free survival (PFS) at three landmark timepoints for 21 disease-risk-prior treatment combinations and overall survival for best supportive care. Within an 8-week timeframe, we piloted with one clinician, conducted online training, collected responses via an online survey using the roulette method and mathematically aggregated results through linear opinion pooling.

RESULTS

Nine experts participated (question response rate: 95%). For first-line intermediate/poor-risk patients, clinicians projected similar PFS for three immune oncology/tyrosine kinase inhibitor (TKI) combinations from 5 years onward and comparable PFS for two TKI monotherapies. Nivolumab + ipilimumab was anticipated to achieve the highest PFS amongst first-line therapies. Expert reasoning incorporated treatment class, clinical experience, and awareness of trial data optimism. Expert estimates were generally somewhat optimistic compared with observed UK real-world evidence and pessimistic compared with observed trial data.

CONCLUSIONS

Structured expert elicitation is a pragmatic, efficient approach for informing long-term survival extrapolations in the context of a rapidly evolving treatment pathway. We demonstrated that expert elicitation is possible even for complex decision problems in a relatively short timeframe.

摘要

背景

在缺乏长期数据的情况下,结构化专家意见征集收集专家判断及相关不确定性,以评估长期外推的临床合理性。

目的

本研究的目的是获取晚期肾细胞癌治疗预期长期结果的专家估计值,以为英国国家卫生与临床优化研究所(NICE)路径试点的成本效益分析提供信息。

方法

使用与医学研究理事会(MRC)方案一致的结构化专家意见征集资源(STEER)库中的材料,规划并开展了此项工作。目标是邀请来自英国不同地区和机构的5至10名肿瘤学家,专家们估计了21种疾病风险-既往治疗组合在三个标志性时间点的无进展生存期(PFS)以及最佳支持治疗的总生存期。在8周的时间内,我们与一名临床医生进行了试点,开展了在线培训,通过轮盘法通过在线调查收集回复,并通过线性意见汇总对结果进行数学汇总。

结果

9名专家参与(问题回复率:95%)。对于一线中/低风险患者,临床医生预计从5年起三种免疫肿瘤学/酪氨酸激酶抑制剂(TKI)组合的PFS相似,两种TKI单药治疗的PFS相当。预计纳武单抗+伊匹木单抗在一线治疗中PFS最高。专家推理纳入了治疗类别、临床经验以及对试验数据乐观性的认识。与观察到的英国真实世界证据相比,专家估计总体上有些乐观,而与观察到的试验数据相比则较为悲观。

结论

结构化专家意见征集是一种务实、有效的方法,可在快速发展的治疗路径背景下为长期生存外推提供信息。我们证明,即使对于相对较短时间内的复杂决策问题,专家意见征集也是可行的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验